Faster blood recovery after cancer transplant? new drug combo shows promise
NCT ID NCT07362810
Summary
This study is testing whether adding a drug called IL-11 to the standard drug G-CSF helps patients' blood cells recover more quickly after a stem cell transplant for blood cancers like multiple myeloma or lymphoma. The goal is to shorten the time patients have low platelet and red blood cell counts, which could reduce their need for transfusions. Researchers are comparing the new two-drug combination against the standard single-drug approach in 224 adults.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The first affiliated hospital of Zhengzhou university
RECRUITINGZhengzhou, Henan, 450052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tongji Hospital of Tongji University
RECRUITINGShanghai, Shanghai Municipality, 200065, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.